Canada’s Drug Agency (CDA-AMC) is a pan-Canadian health organization. Created and funded by Canada’s federal, provincial, and territorial governments, we’re responsible for driving better coordination, alignment, and public value within Canada’s drug and health technology landscape. We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact.
Guidance on the Use of Artificial Intelligence
Except with our prior written permission, you may not use, copy, scrape, download, extract, reproduce, or otherwise access any content from CDA-AMC websites for the purposes of training, testing, developing, improving, or operating any artificial intelligence (AI), machine learning, large language model, generative AI system, or similar automated technology.
These restrictions apply to both direct and indirect use of website content, including using it to create datasets, train algorithms, or support the development or improvement of AI-enabled products or services, including but not limited to those used for commercial purposes or financial gain.
By accessing or using CDA-AMC websites, you agree to comply with these restrictions. Unauthorized use of CDA-AMC website content for AI-related purposes may result in loss of access and legal action.
Disclaimer: CDA-AMC has taken care to ensure that the information in this document was accurate, complete, and up to date when it was published, but does not make any guarantee to that effect. Your use of this information is subject to this disclaimer and the Terms of Use at cda-amc.ca.
The information in this document is made available for informational and educational purposes only and should not be used as a substitute for professional medical advice, the application of clinical judgment in respect of the care of a particular patient, or other professional judgments in any decision-making process. You assume full responsibility for the use of the information and rely on it at your own risk.
CDA-AMC does not endorse any information, drugs, therapies, treatments, products, processes, or services. The views and opinions of third parties published in this document do not necessarily reflect those of CDA-AMC. The copyright and other intellectual property rights in this document are owned by the Canadian Agency for Drugs and Technologies in Health (operating as CDA-AMC) and its licensors.
Questions or requests for information about this report can be directed to Requests@CDA-AMC.ca.
